OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma
Jia Liu, Chunsheng Nie
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 840-849
Closed Access | Times Cited: 13
Jia Liu, Chunsheng Nie
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 840-849
Closed Access | Times Cited: 13
Showing 13 citing articles:
Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation
Yaqing Zhou, Jiaxin Jiang, Shuai He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Yaqing Zhou, Jiaxin Jiang, Shuai He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Environmental Research (2023) Vol. 228, pp. 115767-115767
Closed Access | Times Cited: 16
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Environmental Research (2023) Vol. 228, pp. 115767-115767
Closed Access | Times Cited: 16
The role and prospect of lysine‐specific demethylases in cancer chemoresistance
Yingqi Song, Guan‐Jun Yang, Dik‐Lung Ma, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1438-1469
Closed Access | Times Cited: 14
Yingqi Song, Guan‐Jun Yang, Dik‐Lung Ma, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1438-1469
Closed Access | Times Cited: 14
Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex
Gu Li, Xin Jin, Huaiyuan Liang, et al.
Pharmacological Research (2023) Vol. 192, pp. 106789-106789
Open Access | Times Cited: 12
Gu Li, Xin Jin, Huaiyuan Liang, et al.
Pharmacological Research (2023) Vol. 192, pp. 106789-106789
Open Access | Times Cited: 12
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
Yumin Wang, Shiqian Liu, Yan Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Yumin Wang, Shiqian Liu, Yan Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Inhibition of stress proteins TRIB3 and STC2 potentiates sorafenib sensitivity in hepatocellular carcinoma
Sheng Zhou, Huanji Xu, Tianhong Wei
Heliyon (2023) Vol. 9, Iss. 6, pp. e17295-e17295
Open Access | Times Cited: 5
Sheng Zhou, Huanji Xu, Tianhong Wei
Heliyon (2023) Vol. 9, Iss. 6, pp. e17295-e17295
Open Access | Times Cited: 5
DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma
Xiaochuan Zhang, Wenyu Wang, Shanshan Mo, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 6, pp. 2096-2108
Closed Access | Times Cited: 1
Xiaochuan Zhang, Wenyu Wang, Shanshan Mo, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 6, pp. 2096-2108
Closed Access | Times Cited: 1
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications
Xiaohong Duan, Zhiyao Xing, Lu Qiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Xiaohong Duan, Zhiyao Xing, Lu Qiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma
Hongjun Zhang, Xiangnan Liu, Yongan Chen, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 4
Hongjun Zhang, Xiangnan Liu, Yongan Chen, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 4
MicroRNA Profiling of PRELI-Modulated Exosomes and Effects on Hepatic Cancer Stem Cells
Boyong Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13299-13299
Open Access
Boyong Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13299-13299
Open Access
Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance
Yaquan Cao, Chunli Wu, Liying Ma
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 1
Yaquan Cao, Chunli Wu, Liying Ma
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 1
Preliminary Analysis of the Role of the KDM5 Subfamily in Stomach Adenocarcinoma and Immune Infiltration
立军 赵
Advances in Clinical Medicine (2023) Vol. 13, Iss. 10, pp. 16002-16015
Closed Access
立军 赵
Advances in Clinical Medicine (2023) Vol. 13, Iss. 10, pp. 16002-16015
Closed Access
The Role of Kdm5d in the Development of Chemoresistance to Cisplatin Through Cul4a in Neuroblastoma
Natalia Podhorska, Jan Hraběta, Marie Belhajová, et al.
Research Square (Research Square) (2023)
Open Access
Natalia Podhorska, Jan Hraběta, Marie Belhajová, et al.
Research Square (Research Square) (2023)
Open Access
